These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3028922)

  • 1. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
    Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
    Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
    Leander JD; Hart JC; Zerbe RL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine.
    Leander JD; Zerbe RL; Hart JC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):463-9. PubMed ID: 2991502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior pituitary hormone responses to a kappa-opioid agonist in man.
    Pfeiffer A; Braun S; Mann K; Meyer HD; Brantl V
    J Clin Endocrinol Metab; 1986 Jan; 62(1):181-5. PubMed ID: 3079599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine actions of opioids.
    Pfeiffer A; Herz A
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotomimesis mediated by kappa opiate receptors.
    Pfeiffer A; Brantl V; Herz A; Emrich HM
    Science; 1986 Aug; 233(4765):774-6. PubMed ID: 3016896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats.
    Nikolarakis K; Pfeiffer A; Stalla GK; Herz A
    Brain Res; 1987 Sep; 421(1-2):373-6. PubMed ID: 2825911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate receptor blockade and diurnal pituitary and adrenal hormone levels.
    Leslie RD; Prescott RW; Kendall-Taylor P; Cook D; Weightman D; Ratcliffe J; Ingram MC
    Horm Metab Res; 1985 Feb; 17(2):86-9. PubMed ID: 2985486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the opioid activity of CAM and kappa agonists.
    Furst S; Friedmann T; Kovacs A; Wagner T
    NIDA Res Monogr; 1986; 75():224-7. PubMed ID: 2828975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of kappa-opiate receptor antagonist MR-2266-BS on ACTH and prolactin release].
    Xu RK; Chen L; Li H; Yang SJ; Huang XY
    Sheng Li Xue Bao; 1989 Aug; 41(4):395-401. PubMed ID: 2557673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.